Blood

Blood is a fluid containing biological cells that transports substances through a circulatory system. Its viscosity depends on its cellular content and deformation rate. Treating it as a Newtonian fluid in the Hagen-Poiseuille equation is an approximation that depends on the vessel size and flow conditions.

Oxygen consumption is the rate at which a system uses molecular oxygen in its chemical processes. In aerobic cellular respiration, oxygen participates in reactions supporting energy metabolism. The system boundary might be an isolated preparation, one tissue or the whole body; its definition determines which inflows, outflows and stored oxygen belong in the balance.

For a tissue supplied by blood flow $Q$, with compatible arterial oxygen content $C_a$ and venous oxygen content $C_v$, conservation giveswhen all terms use the same oxygen-amount or reference gas-volume basis. At steady oxygen storage,This is the oxygen form of the Fick principle. It measures net oxygen removal across the stated territory, not oxygen delivery alone.

An original example takes $Q=4.00$ L/min, $C_a=200$ mL oxygen/L and $C_v=140$ mL oxygen/L. Consumption is 240 mL oxygen/min, while arterial delivery is 800 mL/min. If tissue oxygen storage increases by an equivalent 10 mL/min, the same measured inflow–outflow difference instead permits consumption of 230 mL/min. Neglecting accumulation is an assumption to test, especially during transitions.

Respirometry supplies another route: measured gas inflow and outflow, or oxygen decline in a suitable closed chamber, constrain oxygen use. Chamber volume, leakage, sensor response and changes in stored gas or dissolved oxygen affect that inference. A falling oxygen signal is meaningful only after its amount basis and the system boundary are established.

A primary comparison of cardiac-output methods explicitly distinguished thermodilution from Fick output calculated using estimated oxygen uptake.^[ref] An assumed consumption value is not the same observation as direct measurement. Whole-body calculations also require mixed venous oxygen content, while a regional venous sample belongs with that region's flow. Report the measurement or estimation method alongside the resulting rate.

The arteriovenous oxygen content difference is arterial oxygen content minus the venous oxygen content leaving the same tissue bed:It measures oxygen removed per unit volume of blood. For the whole body, the venous term is mixed venous oxygen content; for coronary oxygen uptake, the arterial and venous sampling sites must represent the coronary circulation. Oxygen content includes both hemoglobin-bound and dissolved oxygen, so this quantity is not simply the difference between two oxygen saturation readings.^[ref]

If $C_a=20$ and $C_v=15$ mL/dL, then $\Delta C_{{\mathrm{O}}_2}=5$ mL/dL. With blood flow $Q=50$ dL/min, the Fick principle gives oxygen consumption $Q\Delta C_{{\mathrm{O}}_2}=250$ mL/min. The same content difference at half the blood flow gives half the oxygen transfer. Conversely, at fixed oxygen transfer, a fall in blood flow requires a larger content difference in the steady-state balance.

Subtraction also has a useful measurement uncertainty structure. If $u_a,u_v$ are the standard uncertainties of the two content measurements, thenThe covariance term accounts for shared errors.^[ref] A common additive offset cancels in the difference, whereas a common multiplicative gain error scales the difference. Matched sampling and knowledge of shared measurement calibration errors can therefore matter as much as the repeatability of either measurement separately.

Venous oxygen content is the amount of oxygen per specified volume of blood sampled from a venous site. The site matters: a local tissue outflow, a coronary sinus mixture and a more widely mixed return need not have the same value. Venous describes a circulation route; the pulmonary vein carries blood returning from the lungs after oxygen uptake there.^[ref]

For a matched steady tissue balance,A chosen inflow content $C_a=0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$, flow $250\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$ and uptake $30\mathrm{mL}{\mathrm{O}}_2\mathrm{mi}{\mathrm{n}}^{-1}$ imply $C_v=0.08$. The value depends on uptake relative to flow, not simply on whether the sample is called venous.

Mixing obeys an oxygen-amount balance. For streams with compatible content definitions and negligible exchange during mixing,In an original example, flows $100$ and $50\mathrm{mL}\mathrm{mi}{\mathrm{n}}^{-1}$ have contents $0.05$ and $0.20\mathrm{mL}{\mathrm{O}}_2\mathrm{m}{\mathrm{L}}^{-1}$. Their mixture content is $0.10$, not the unweighted mean $0.125$. A mixed venous oxygen content is therefore defined by the contributing blood pools and their flows.

Like arterial oxygen content, venous content includes oxygen bound to hemoglobin and dissolved oxygen. A saturation number alone is not the same amount-per-volume quantity. The primary whole-blood oximeter study measured carrier concentration and saturation separately, illustrating the need to distinguish the inputs to a content calculation.^[ref]

The arteriovenous oxygen content difference should pair compatible territories and times before it is used to estimate coronary oxygen uptake. Comparing an arterial input with an unrelated venous mixture can combine different regions into a number that represents neither intended tissue balance.

Mixed venous oxygen content is the oxygen content of blood after the returning venous streams have mixed, representing whole-body venous return to the right side of the heart. It is the venous quantity required with arterial oxygen content in the whole-body Fick principle. A single regional vein need not have this content: different tissues remove different amounts of oxygen and return different blood flow rates.

The mixing rule follows from conservation of mass. If streams have blood flow rates $Q_i$ and venous oxygen content values $C_i$, with no oxygen exchange during mixing,For two constructed streams, $100$ mL/min at $0.05$ mL of oxygen per mL of blood and $50$ mL/min at $0.20$ mL/mL carry $5$ and $10$ mL/min of oxygen. Their mixture has content $15/150=0.10$ mL/mL, not the unweighted mean $0.125$ mL/mL. The correct weights are volume blood flow rates.

The right atrium receives several returns before blood passes through the right ventricle and pulmonary trunk.^[ref] A downstream sample can represent their mixture only to the extent that the streams have actually mixed and the sampling interval represents the desired state. Replacing that sample with one taken from a particular upstream vein introduces a representativeness assumption. Likewise, averaging oxygen saturation values is not generally an oxygen-content balance when hemoglobin concentrations differ. The whole-body balance is about amounts of transported oxygen, not averages of instrument displays.

Arterial oxygen content is the amount of oxygen carried per specified volume of arterial blood. It includes oxygen bound to hemoglobin and oxygen dissolved in the liquid phase. It differs from oxygen partial pressure and from the fractional occupancy represented by oxygen saturation.^[ref]

A useful quantity model isHere $H$ is total hemoglobin concentration, $F_{{\mathrm{O}}_{2}Hb,a}$ the fractional oxyhemoglobin, $\beta$ a specified oxygen-binding conversion factor and $\alpha$ the dissolved-oxygen coefficient for the stated conditions. Units must be compatible: for example, $H$ in grams per decilitre and $\beta$ in millilitres oxygen per gram give a bound contribution in millilitres oxygen per decilitre blood.

Using the manufacturer's worked coefficient $\beta =1.34\mathrm{mL}{\mathrm{O}}_2{\mathrm{g}}^{-1}$, a chosen $H=15\mathrm{g}\mathrm{d}{\mathrm{L}}^{-1}$ and fraction $0.98$ give bound oxygen about $19.70\mathrm{mL}\mathrm{d}{\mathrm{L}}^{-1}$. Halving $H$ gives about $9.85$ despite unchanged fraction. The dissolved contribution must still be added for total content.^[ref] These are amount calculations, not clinical target values.

The saturation definition matters. Total hemoglobin can include carboxyhemoglobin and methemoglobin, so a fraction defined using only oxygenated plus deoxygenated functional hemoglobin should not automatically be multiplied by total $H$ as though every included form had the same oxygen-binding status.^[ref]

A primary 1989 instrument illustrates why carrier amount and saturation are separate observations: it illuminated whole blood in a capillary tube with red and infrared LEDs, detected scattered light and computed hemoglobin concentration and saturation from distinct signal relationships.^[ref]

For physiological transport, coronary oxygen delivery is flow times content. A pressure or saturation observation alone cannot supply that product without the remaining quantity information. The arterial sampling site, time and measurement definitions are part of the content result.

A blood cell is a cellular component of blood, including red blood cells and white blood cells. Red blood cells transport oxygen using hemoglobin; white blood cells participate in the immune system. The usual blood-count categories also include platelets, which in humans are cell fragments rather than complete nucleated biological cells.^[ref] Conversely, a mature human red blood cell is a whole specialized biological cell without a cell nucleus; possessing a cell nucleus is not a universal test for membership.

The Coulter counter connects cell counting to electric current. Wallace H. Coulter's patent passes a diluted suspension through a narrow conducting path between electrodes. A particle changes the electric current as it passes, yielding a countable pulse. The known sampled volume and dilution convert counts to an estimate for the original sample; simultaneous passage of particles can mask events.^[ref]

For a synthetic arithmetic example, count 5,000 cells in $1\mu \mathrm{L}$ of a sample diluted by a factor of 1,000. The original sample then contains an estimated $5000\times 1000/1=5,000,000$ cells per microlitre. This illustrates counting and dilution, not a clinical reference range. A pulse alone does not establish which cell type produced it; the preparation and classification method must specify that.

Blood serum is the liquid recovered after blood has clotted and the clot and blood cells have been separated. In particular, fibrinogen has been converted into the fibrin network of the clot. Blood plasma is instead the liquid portion of blood whose clotting has been prevented, so it retains fibrinogen.^[ref]

A two-tube comparison makes the distinction concrete. Allow one sample to clot before centrifugation; prevent clotting in the other and then centrifuge it. Both yield liquid fractions, but the preparations have undergone different biochemical processes. Blood serum still contains many proteins, including antibodies; it is not a protein-free version of blood. Consequently an assay validated for one specimen type should not be interpreted as though sample preparation were irrelevant.

A small cellular fragment produced by a megakaryocyte.

Formation of the cellular constituents of blood; normal adult production is chiefly associated with bone marrow.

A megakaryocyte is a large marrow cell that produces platelets from its cytoplasmic material. Its lineage and unusual nuclear organization distinguish it from a mature circulating platelet. Platelet production is therefore not ordinary division into several equivalent daughter cells.

Production of red blood cells from dividing precursors, distinguished from division of mature mammalian red blood cells.

The decreasing production function and increasing linear loss have one positive constant equilibrium $u_{\ast }$. It scales as ${\delta }^{-1/(n+1)}$ for small loss and ${\delta }^{-1}$ for large loss. With $a=n{u}_{\ast }^{n-1}/(1+u_{\ast }^n{)}^2>0$, the linear characteristic equation is $\sigma +\delta +a{e}^{-\sigma d}=0$. It has no real nonnegative root, and zero is never a root. Thus loss of stability from the zero-delay stable state must occur through a nonzero imaginary conjugate pair.

If $a>\delta$, the first crossing has $\omega =\sqrt{a^2-{\delta }^2}$ and $d_c=\arccos (-\delta /a)/\omega$. Differentiation of the characteristic equation gives $\mathrm{Re}{\sigma }^{\prime }(d_c)={\omega }^2/[(1+\delta d_c{)}^2+{\omega }^2{d}_c^2]>0$, proving transversality. If $a\le \delta$, the magnitude inequality $|\sigma +\delta |=a|e^{-\sigma d}|$ rules out a root in the closed right half-plane. The model needs an initial history on the whole delay interval. The delay represents a production/maturation lag rather than instantaneous production controlled by the current cell count.

A reticulocyte is a recently formed red blood cell retaining detectable RNA-associated material. Its maturation state differs from a fully mature erythrocyte. The proportion of reticulocytes provides information about red-cell production rather than simply the total amount of hemoglobin present.

An erythroblast is a developing red-cell precursor. Its successive changes include hemoglobin accumulation and, in mammals, eventual loss of the nucleus before the mature circulating state. Cell identity and developmental stage must therefore be specified when interpreting a blood-forming population.

Blood plasma is the fluid component of blood in which cells are suspended. It contains water, proteins and dissolved substances, including components of coagulation. Serum is obtained after clotting and therefore is not compositionally identical to plasma.

A plasma protein is a protein present in blood plasma. Transport, immune functions, coagulation and osmotic effects are among their different roles. Total protein concentration does not specify the amount or activity of any one component.

A coagulation factor participates in the regulated reactions leading to formation of a clot. Different factors have different activation and interaction roles. Their concentration and functional activity are distinct measurements, and coagulation is only one part of haemostasis.

Albumin is a major plasma protein contributing to transport of bound molecules and to plasma osmotic properties. Its concentration reflects production, distribution and losses. A measured level is therefore not a direct measurement of one nutritional input or one organ function alone.